200 articles – 63 references  [version française]
Short view
Timing of onset of cognitive decline: results from Whitehall II prospective cohort study.
Singh-Manoux A., Kivimaki M., Glymour M. M., Elbaz A., Berr C., Ebmeier K. P., Ferrie J. E., Dugravot A.
BMJ 344 (2012) d7622 - http://www.hal.inserm.fr/inserm-00677226
 (22223828) 
Timing of onset of cognitive decline: results from Whitehall II prospective cohort study.
Archana Singh-Manoux () 1, 2, 3, Mika Kivimaki2, M Maria Glymour4, Alexis Elbaz5, Claudine Berr6, 7, Klaus Ebmeier8, Jane Ferrie9, Aline Dugravot1
1:  CESP - Centre de recherche en épidémiologie et santé des populations
INSERM : U1018 – Université Paris XI - Paris Sud – Hôpital Paul Brousse – Assistance publique - Hôpitaux de Paris (AP-HP)
16 avenue Paul Vaillant Couturier 94807 Villejuif Cedex, France
France
2:  Department of Epidemiology and Public Health
http://www.ucl.ac.uk/epidemiology/staff/singh-manoux.htm
University College of London (UCL)
1-19 Torrington Place London WC1E 6BT
United Kingdom
3:  Centre de Gérontologie
Assistance publique - Hôpitaux de Paris (AP-HP) – Hôpital Ste Périne
Paris
France
4:  Department of Society, Human Development, and Health
Harvard School of Public Health
United States
5:  Neuroépidémiologie
INSERM : U708 – Université Pierre et Marie Curie (UPMC) - Paris VI
GH Pitie-Salpetriere 47, Boulevard de L'Hopital 75651 PARIS CEDEX 13
France
6:  Neuropsychiatrie : recherche épidémiologique et clinique
INSERM : U1061 – Université Montpellier I
Hôpital La Colombière 39 AV Charles Flahault BP 34493 -Pav 42 Calixte Cavalier 34093 CEDEX 5 Montpellier
France
7:  CMRR - Centres Mémoire de Ressources et de Recherche Montpellier
Hôpital Gui de Chauliac – CHRU Montpellier
80 avenue Augustin fliche - 34295 Montpellier cédex 5
France
8:  Department of Psychiatry
Oxford University – Warneford Hospital
Oxford
United Kingdom
9:  School of Community and Social Medicine
University of Bristol
Bristol
United Kingdom
OBJECTIVES: To estimate 10 year decline in cognitive function from longitudinal data in a middle aged cohort and to examine whether age cohorts can be compared with cross sectional data to infer the effect of age on cognitive decline. DESIGN: Prospective cohort study. At study inception in 1985-8, there were 10,308 participants, representing a recruitment rate of 73%. SETTING: Civil service departments in London, United Kingdom. PARTICIPANTS: 5198 men and 2192 women, aged 45-70 at the beginning of cognitive testing in 1997-9. MAIN OUTCOME MEASURE: Tests of memory, reasoning, vocabulary, and phonemic and semantic fluency, assessed three times over 10 years. RESULTS: All cognitive scores, except vocabulary, declined in all five age categories (age 45-49, 50-54, 55-59, 60-64, and 65-70 at baseline), with evidence of faster decline in older people. In men, the 10 year decline, shown as change/range of test × 100, in reasoning was -3.6% (95% confidence interval -4.1% to -3.0%) in those aged 45-49 at baseline and -9.6% (-10.6% to -8.6%) in those aged 65-70. In women, the corresponding decline was -3.6% (-4.6% to -2.7%) and -7.4% (-9.1% to -5.7%). Comparisons of longitudinal and cross sectional effects of age suggest that the latter overestimate decline in women because of cohort differences in education. For example, in women aged 45-49 the longitudinal analysis showed reasoning to have declined by -3.6% (-4.5% to -2.8%) but the cross sectional effects suggested a decline of -11.4% (-14.0% to -8.9%). CONCLUSIONS: Cognitive decline is already evident in middle age (age 45-49).
Life Sciences/Health Care Sciences and Epidemiology
English
1756-1833

Article in peer-reviewed journal
BMJ (BMJ)
Publisher BMJ Publishing Group: BMJ
ISSN 0959-8138 (eISSN : 1468-5833)
international
2012
2011-01-05
344
d7622

Adult – Age of Onset – Aged – Aging – Cognition Disorders – Educational Status – Epidemiologic Methods – Female – Humans – London – Male – Middle Aged – Neuropsychological Tests
ASM is supported by a "European Young Investigator Award" from the European Science Foundation and the National Institute on Aging, NIH (R01AG013196; R01AG034454). MK is supported by the BUPA Foundation, the National Institutes of Health (R01HL036310; R01AG034454) and the Academy of Finland. The Whitehall II study is also supported by a grantfrom the British Medical Research Council (G0902037) and the British Heart Foundation.
Attached file list to this document: 
PDF
Singh-Manoux_et_al_BMJ_2012.pdf(336 KB)